Compassionate Use of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT06028594 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT06028594
- Sponsor
- Regeneron Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.